Financials
- Market Capitalization 134.12 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
29.59
売上高対価格比率
9.75
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 200 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 814.73 USD | -1.57% | -0.78% | +4.22% | +46.27% | 83.88 B USD | ||
| 269 | ARGX argenx SE - American Depositary Shares | 1010.02 USD | -2.24% | -1.61% | +16.39% | +32.48% | 62.50 B USD | ||
| 290 | MRNA Moderna, Inc. - Common Stock | 142.76 USD | -1.92% | -4.14% | +138.21% | +473.10% | 56.99 B USD | ||
| 347 | RVMD Revolution Medicines, Inc. - Common Stock | 209.61 USD | -0.20% | +0.58% | +1.90% | +278.36% | 44.93 B USD |